Atlas Trials

EGFR Mutation-negative and ALK Rearrangement-negative

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR Mutation-negative and ALK Rearrangement-negative

RecordFirmDate
Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study (NCT07696832)Guangdong Association of Clinical Trials2026-01-20

Track EGFR Mutation-negative and ALK Rearrangement-negative automatically

Every clearance here is in the API, with alerts when new ones post.